In order to adapt to the Oncology Care Model (OCM), Regional Cancer Care Associates had to undergo the process of adjusting and customizing its electronic medical records, explained CEO Terrill Jordan.
In order to adapt to the Oncology Care Model (OCM), Regional Cancer Care Associates had to undergo the process of adjusting and customizing its electronic medical records, explained CEO Terrill Jordan.
Transcript
Did you have to upgrade your electronic health records to adapt to OCM requirements, and what was that process like?
We did and it wasn’t so much as upgrade as we had to customize a lot of the workflows. What we found was that the EMRs weren’t developed with value based in mind while there were a lot of structure fields, the structure fields weren’t in a place to be used within the workflow. So what we had to do was customize little drop down boxes, we had to customize different fields so our clinicians could put structured data in along with their daily exercise of seeing patients. That was the main change with the EMR.
In terms of some of the other software we had, we found that a lot of the other software wasn’t meant to interface with the EMR—and the EMR being so critical to our understanding of the clinical, marrying that up with the claims data, marrying that up with our payment data—we found that the interface was also an issue.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More